phase readout

NCT06776952: A Randomized, Double-blind, Multicenter Phase III Study of XNW5004 Tablets in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

RECRUITINGupdated 5d ago

community read0 votes

Sponsor: Evopoint Biosciences Inc.. Phase: PHASE3. Conditions: Relapsed/Refractory Peripheral T Cell Lymphoma

Data sources

last refreshed 2h ago

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?